1090
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
RISK FACTORS FOR THE DEVELOPMENT OF CLIMACTERIC DISORDERS IN
WOMEN WITH THE METABOLIC SYNDROME
Jo’rayeva Gulhayo Jalol qizi
Asian International University
https://doi.org/10.5281/zenodo.14759691
Abstract. This article describes the risk factors for the development of climacteric
disorders in women with metabolic syndrome.
Key words: menopause, metabolic syndrome, estrogen, atherosclerotic disease, insulin
resistance, diabetes, osteoporosis, climacteric, lipid spectrum.
ФАКТОРЫ РИСКА РАЗВИТИЯ КЛИМАКТЕРИЧЕСКИХ РАССТРОЙСТВ У
ЖЕНЩИН С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ
Аннотация. В статье описаны факторы риска развития климактерических
расстройств у женщин с метаболическим синдромом.
Ключевые
слова:
менопауза,
метаболический
синдром,
эстроген,
атеросклеротическое заболевание, инсулинорезистентность, сахарный диабет,
остеопороз, климакс, липидный спектр.
Relevance:
Menopause is the period that causes the most anxiety among women. Among
them, women are more afraid of being overweight. The results of the 2019-2022 National Research
on Nutrition of the Ministry of Health of the Republic of Uzbekistan show that in the conditions
of Uzbekistan, women with metabolic syndrome are more likely to be 40-55 years old than women
aged 20-39. more common in women. This age corresponds to perimenopause. During this period,
the development of hormonal changes in the female div is observed. As we know, the estrogen
hormone is important in the management of energy balance and sex hormones are also important
for the metabolism of adipose tissue and other organs. As a result of a sharp decrease in the
production of the estrogen hormone and an unhealthy lifestyle, there are risk factors that have a
serious impact on a woman's health. Such risk factors include cardiovascular atherosclerotic
disease, insulin resistance, and diabetes and osteoporosis.
Objective
: To monitor and study risk factors that may develop in perimenopause and
climactic women with metabolic syndrome.
Materials and methods
: This study was conducted among the employees of maternity
complex No. 9, which is one of the bases of the Department of Obstetrics and Gynecology of the
Tashkent Medical Academy, and among women who applied to the gynecology department.
1091
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
In the study, 72 women aged 42-56 were examined and divided into 4 groups. Group 1: 20
women with metabolic syndrome, but climacteric changes have not yet been observed; Group 2:
20 menopausal women without metabolic syndrome; Group 3: 20 women with metabolic
syndrome and menopause. Group 4 (control) 12 women make up the control group and are
conditionally healthy women. This study: dietary questionnaires, questionnaires on the
manifestation of climacteric symptoms, and retrospective and anamnesis collection, as well as
clinical (div mass index, arterial blood pressure), laboratory (blood glucose, insulin, lipid
spectrum) conducted through inspections.
Results
: According to the results of the study, the analyzes showed women aged 42-56
years. The average age of women in group 1 was 45.2±4 years, the average age of women in group
2 was 51.6±3 years, and the average age of women in group 3 was 52.6±3 years. In group 1 women
without climacteric changes, the incidence of metabolic syndrome with total obesity was 40%, and
the same amount of women in group 2, i.e. 40% had abdominal obesity and 15% had total obesity.
This means that it is caused by hormonal changes during the climax. An increase in arterial
blood pressure was noted in 20% of women in group 1, and in 35% of women in group 2. 15% of
women in group 1 and 10% of women in group 2 had insulin resistance. In addition, 3 (15%) of
women in group 1 had obesity and hypertension, 2 (10%) had obesity and insulin resistance.
Women in group 3 form the category of women with both climacteric and metabolic
changes, 6 (30%) of them have cardiovascular disease (angina, coronary artery disease), 5 (25%)
have diabetes, 2 patients (10%) had osteoporosis and 7 patients (35%) had hypertension.
Conclusion
: In women with metabolic syndrome, the occurrence of risk factors such as
cardiovascular diseases, insulin resistance and diabetes, hypertension is higher than in women
without metabolic syndrome. Hormonal changes during the climax intensify the processes caused
by the metabolic changes in women, and lead to the negative side of the process.
REFERENCES
1.
Rajabova Oygul Islomovna.(2024). VIRUSLI GEPATITLAR VA TUG‘RUQDAN
KEYINGI
ERTA
QON
KETISHLARNI
KAMAYTIRISHNING
YANGI
TEXNOLOGIYALARI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ, 39(5), 99–106.
https://www.newjournal.org/index.php/01/article/view/11723
2.
Rajabova Oygul Islomovna. (2024). A Comparative Analysis of the Effectiveness of
Vaginal Progesterone, Cervical Pesar, and Their Combination for Preventing the Risk of
Premature Labor in High-Risk Pregnant Women BEST JOURNAL OF INNOVATION IN
SCIENCE,
RESEARCH
AND
DEVELOPMENT,
3(3),
440-446.
http://www.bjisrd.com/index.php/bjisrd/article/view/1849/1700
1092
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
3.
Rajabova Oygul Islomovna.(2024). MODERN CONCEPT OF RECURRENT VAGINAL
INFECTIONS
IN
WOMEN
OF
REPRODUCTIVE
AGE,
3(04),
128-131.
https://jhlsr.innovascience.uz/index.php/jhlsr/article/view/518/455
4.
Rajabova Oygul Islomovna.(2024).
METHODS OF PHARMACOTHERAPEUTIC
TREATMENT OF ABNORMAL UTERINE BLEEDING IN GIRLS, 3(5),193-197
https://mudarrisziyo.uz/index.php/pedagogika/article/view/945
5.
Rajabova Oygul Islomovna.(2024).
Method Stopping Atonic Bleeding From the Uterus after
Childbirth Using Balloon Tamponade
International Journal of Alternative and
Contemporary Therapy with U.S. ISSN 2995-5378
In Volume 2, Issue 9 (2024)
https://medicaljournals.eu/index.php/IJACT/article/view/965
6.
Rajabova Oygul Islomovna.(2024).
Tactics for carrying women at high risk of recurrent
miscarriage.
New renaissance journal ResearchBib IF-2023: 11.01, ISSN: 3030-3753,
Valume 1 Issue 8 Pp:509-514
https://doi.org/10.5281/zenodo.13982730
7.
Islomovna,
R.
O.
CHARACTERISTICS
OF
UROGENITAL
TRACT
MICROBIOCENOSIS IN WOMEN WITH NON-DEVELOPING PREGNANCY.
https://doi.org/10.5281/zenodo.14528590
8.
Jo’rayeva, G. (2024). COMBINATION OF DIABETES AND METABOLIC
SYNDROME.
Modern Science and Research
,
3
(12), 691-696.
9.
https://doi.org/10.5281/zenodo.14528640
10.
Numonova,
A.,
&
Narzulayeva,
U.
(2023).
EPIDEMIOLOGY
AND
ETIOPATHOGENESIS OF CHF. Наука и инновация, 1(15), 115-119.
11.
Орипова Озода Олимовна, Самиева Гулноза Уткуровна, Хамидова Фарида Муиновна,
& Нарзулаева Умида Рахматуллаевна (2020). Состояние плотности распределения
лимфоидных клеток слизистой оболочки гортани и проявления местного иммунитета
при хроническом ларингите (анализ секционного материала). Academy, (4 (55)), 83-
86.
12.
Umida Rakhmatulloevna Narzulaeva, & Xamrayeva Muxlisa Farmon qizi. (2023).
ETIOPATHOGENESIS OF HEMOLYTIC ANEMIA. Web of Medicine: Journal of
Medicine,
Practice
and
Nursing,
1(1),
1–4.
Retrieved
from
https://webofjournals.com/index.php/5/article/view/26
13.
Нарзулаева, У., Самиева, Г., & Насирова, Ш. (2023). Гемореологические нарушения
на ранних стадиях гипертензии в жарком климате. Журнал биомедицины и практики,
1(1), 221–225.
https://doi.org/10.26739/2181 -9300-2021-1-31
14.
Umida Rakhmatulloevna Narzulaeva. (2023). Important Aspects of Etiology And
Pathogenesis of Hemolytic Anemias. American Journal of Pediatric Medicine and Health
1093
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
Sciences
(2993-2149),
1(7),
179–182.
Retrieved
from
https://grnjournal.us/index.php/AJPMHS/article/view/817
15.
Нарзулаева, У. Р., Самиева, Г. У., & Насирова,
Ш. Ш. (2021). ИССИҚ ИҚЛИМДА
КЕЧУВЧИ ГИПЕРТОНИЯ КАСАЛЛИГИНИНГ БОШЛАНҒИЧ БОСҚИЧЛАРИДА
ГЕМОРЕОЛОГИК БУЗИЛИШЛАР. ЖУРНАЛ БИОМЕДИЦИНЫ И ПРАКТИКИ, 6(1).
16.
Нарзулаева, У., Самиева, Г., Лапасова, З., & Таирова, С. (2023). Значение диеты в
лечении артериальной гипертензии. Журнал биомедицины и практики, 1(3/2), 111–
https://doi.org/10.26739/2181-9300-2021-3-98
17.
Narzulaeva Umida Rakhmatulloevna, Samieva Gulnoza Utkurovna, & Ismatova Marguba
Shaukatovna (2020). SPECIFICITY OF THE CLINICAL COURSE OF THE INITIAL
STAGES OF HYPERTENSION IN ARID ZONES OF UZBEKISTAN AND NON-DRUG
APPROACHES TO TREATMENT. Кронос, (4 (43)), 15-17.
